DAIHAN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 023910 for the last quarter is 54.85 B KRW, and it's 12.20% higher compared to the previous quarter. The net income of Q3 24 is 8.49 B KRW.